The use of antenatal corticosteroids for fetal maturation: Clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine foundation

Themistoklis Dagklis, Cihat Sen, Ioannis Tsakiridis, Cecilia Villalaín, Allegaert Karel Allegaert, Sven Wellmann, Satoshi Kusuda, Bernat Serra, Manuel Sanchez Luna, Erasmo Huertas, Nicola Volpe, Rodrigo Ayala, Nelly Jekova, Amos Grunebaum, Milan Stanojevic

Research output: Contribution to journalArticlepeer-review

Abstract

This practice guideline follows the mission of the World Association of Perinatal Medicine in collaboration with the Perinatal Medicine Foundation, bringing together groups and individuals throughout the world, with the goal of improving the use of antenatal corticosteroids (ACS) for fetal maturation. In fact, this document provides further guidance for healthcare practitioners on the appropriate use of ACS with the aim to increase the timely administration and avoid unnecessary or excessive use. Therefore, it is not intended to establish a legal standard of care. This document is based on consensus among perinatal experts throughout the world and serves as a guideline for use in clinical practice.

Original languageEnglish
Pages (from-to)375-385
Number of pages11
JournalJournal of Perinatal Medicine
Volume50
Issue number4
DOIs
StatePublished - 1 May 2022

Bibliographical note

Publisher Copyright:
© 2022 Walter de Gruyter GmbH, Berlin/Boston.

Keywords

  • corticosteroids
  • fetal maturation
  • guideline
  • pregnancy
  • preterm delivery

Fingerprint

Dive into the research topics of 'The use of antenatal corticosteroids for fetal maturation: Clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine foundation'. Together they form a unique fingerprint.

Cite this